1Metra M,Giubbini R,Nodari S,et al.Differential effects of beta-blockers in patients with heart failure:a prospective,randomized,double-blind comparison of the lotg-term effects of metoprolol versus carvedilol.Circulation,2000,102:546-51
2Packer M,Antonopoulos GV,Berlin JA,et al.Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure:results of a metaanalysis.AmHeartJ,2001,141:899-907
3MaackC,ElterT,NickenigG,etal.Prospective crossover comparison of carvedilol and metoprolol in patients with chronic heart failure.JAmCollCardiol2001,38:939-46
4Hall.SA,Cigarroa CG,Marcoux L,Risser RC,Grayburn PA.Eichhorn EJ.Time course of improvement in left ventricular function,and geometry in patients with congestive heart failure treated with adrenergic blockade.JAm Coll Cardiol,1995,25:1154-1161
5Hunt SA,Baker DW,Chin MH,etal.ACC/AHA guide lines for the evaluation and management of chronic heart failure in the adult:executive summary.A report of the AmericanCollege of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure).J AmColl Cardiol,2001,38:2101-13
6K.Sliwa,G.R.NortonandN.Koneetal.,Impactof initiating carvedilol before angiotensinconverting enzyme inhibit or therapy on cardiac function in newly diagnosed heart failure,JAmCollCardio144(2004):1825-1830
7R.Willenheimer,E.Erdmann,F.Follathetal.CIBIS-Ⅲ investigators,Comparison of treatmentinitiation with bisoprololversus enalapril in chronic heart failure patients rationale and design of CIBIS-Ⅲ,Eur J HeartFail,2004:493-500
8EichhornEJ,BristowMR.Practicalguidelines for initiation of beta-adrenergic blockade in patients with chronic heart failure.Am J Cardiol,1997:79:794-8
9Consensus recommendations for the management of chronic heart failure.On behalf of the membership of the advisory council to improve outcomes nationwide in heart failure[].The American Journal of Cardiology.1999
3Peter JS,Gaetano MD. Sympathetic-parasympathetic interac- tion in health and disease: abnormalities and relevance in heart failure[J]. Heart Fail Rev,2011,2(16)..101-107.
4Barron HV. Autonomic nervous system and sudden cardiac death[J]. J Am Coll Cardiol, 1996,27(5) .. 1053-1056.
5Brunner-La,Roeca HP,Jennings GL. Effect of cardiac sympa- thetic nervous activity on mode of death in congestive heart failure [J]. Eur Heart J,2001,22(13) :1136-1143.
6Mann DL, Kent RL,Cooper Gt, et al. Adrenergic effects on the biology of the adult mammalian cardiocyte[J]. Circulation, 1992,85(2) : 790-804.
7Fowler MB, Laser JA, Hopkins GL, et al. Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response[J]. Circulation,1986,74(6):1290-1302.
8Hare JM,Keaney JF,Balligand JL, et al. Role of nitric oxide in parasympathetic modulation of beta adrenergic myocardial contractility in normal dogs[J]. J Clin Invest , 1995,95 (1) 360-366.
9Vanoli E, Adamson PB. What does the future hold for the management of chronic heart {ailure[J]. Eur Heart J Suppl, 2006,8(1),C51-C57.
10Rzerkt D, Gorska D. Drugs used in cardiovascular diseases and cytokines[J]. Wlad Lek, 2006,59 (3-4) : 232-237.
